Melatonin, a dietary supplement often used by insomnia sufferers, could be used to possibly help prevent or treat COVID-19, according to researchers at the Cleveland Clinic.
The hormone — which regulates the sleep-wake cycle — was associated with an almost 30 percent reduced likelihood of contracting the disease, the scientists said in research published in the journal PLOS Biology, KIRO 7 reported.
Additional studies are required about the over-the-counter supplement, the researchers said.
“It is very important to note these findings do not suggest people should start to take melatonin without consulting their physician,” lead researcher Feixiong Cheng of the Cleveland Clinic’s Genomic Medicine Institute said in a statement, WebMD reported.
“Large-scale observational studies and randomized controlled trials are critical to validate the clinical benefit of melatonin for patients with COVID-19,” he added. “But we are excited about the associations put forth in this study and the opportunity to further explore them.”
Read more at NY Post.